Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)

Q: What does CUSIP 15673T100 represent in this 13F holders report?

CUSIP 15673T100 is the security identifier for IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q2 2022?

51 institutional investors reported IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 15673T100

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 87,670,044
Total 13F shares: 21,756,667
Share change: -367,655
Total reported value: $182,752,181
Price per share: $8.40
Number of holders: 51
Value change: -$3,241,178
Number of buys: 29
Number of sells: 11

Quarterly Holders Quick Answers

What is CUSIP 15673T100?
CUSIP 15673T100 identifies IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 15673T100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	9.4%	8,229,291	$103,607,000	—	31 Mar 2022	13F
Casdin Capital, LLC	13F	Company	3.7%	3,206,380	$40,368,000	—	31 Mar 2022	13F
BAYER AKTIENGESELLSCHAFT	3/4/5	10%+ Owner	— class O/S missing	12,675,838	$18,886,999	—	22 Jun 2021	3/4/5
FEDERATED HERMES, INC.	13F	Company	1.3%	1,164,094	$14,656,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	1.2%	1,028,257	$12,946,000	—	31 Mar 2022	13F
Deep Track Capital, LP	13F	Company	1.1%	926,469	$11,664,000	—	31 Mar 2022	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1%	914,094	$11,508,000	—	31 Mar 2022	13F
Avidity Partners Management LP	13F	Company	0.99%	865,000	$10,890,000	—	31 Mar 2022	13F
FUJIFILM Cellular Dynamics, Inc.	3/4/5	10%+ Owner	— class O/S missing	6,955,207	$10,363,258	—	22 Jun 2021	3/4/5
VANGUARD GROUP INC	13F	Company	0.94%	819,762	$10,320,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	0.8%	701,338	$8,830,000	—	31 Mar 2022	13F
Octagon Capital Advisors LP	13F	Company	0.75%	658,266	$8,288,000	—	31 Mar 2022	13F
HHLR ADVISORS, LTD.	13F	Company	0.7%	614,095	$7,731,000	—	31 Mar 2022	13F
Logos Global Management LP	13F	Company	0.63%	550,259	$6,928,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.53%	467,390	$5,884,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.44%	383,502	$4,828,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.31%	267,905	$3,372,000	—	31 Mar 2022	13F
DAFNA Capital Management LLC	13F	Company	0.29%	256,892	$3,234,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.25%	222,033	$2,795,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	0.24%	208,082	$2,620,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.15%	134,484	$1,693,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.1%	91,182	$1,148,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.07%	59,119	$744,000	—	31 Mar 2022	13F
Walleye Capital LLC	13F	Company	0.06%	50,908	$641,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.05%	45,727	$575,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.05%	43,881	$552,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.04%	32,458	$409,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.03%	24,990	$290,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.03%	22,437	$282,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	20,746	$261,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	14,961	$188,000	—	31 Mar 2022	13F
HARBOURVEST PARTNERS LLC	13F	Company	0.02%	14,631	$184,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.02%	13,908	$175,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	13,908	$175,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	13,651	$172,000	—	31 Mar 2022	13F
MetLife Investment Management, LLC	13F	Company	0.01%	12,167	$153,183	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.01%	11,589	$146,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	10,353	$131,000	—	31 Mar 2022	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	8,604	$108,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	7,401	$93,000	—	31 Mar 2022	13F
HERSHEY TRUST CO	13F	Company	0.01%	4,723	$59,000	—	31 Mar 2022	13F
BARCLAYS PLC	13F	Company	0%	2,815	$36,000	—	31 Mar 2022	13F
STRS OHIO	13F	Company	0%	2,700	$33,000	—	31 Mar 2022	13F
CITIGROUP INC	13F	Company	0%	1,843	$23,000	—	31 Mar 2022	13F
AMALGAMATED BANK	13F	Company	0%	1,720	$22,000	—	31 Mar 2022	13F
Amalgamated Financial Corp.	13F	Company	0%	1,720	$22,000	—	31 Mar 2022	13F
Legal & General Group Plc	13F	Company	0%	1,660	$21,000	—	31 Mar 2022	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0%	1,426	$17,953	—	31 Mar 2022	13F
ROYAL BANK OF CANADA	13F	Company	0%	1,065	$13,000	—	31 Mar 2022	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	905	$11,000	—	31 Mar 2022	13F

Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q2 2022

As of 30 Jun 2022, Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,756,667 shares. The largest 10 holders included FMR LLC, Casdin Capital, LLC, BlackRock Inc., FEDERATED HERMES, INC., Deep Track Capital, LP, VANGUARD GROUP INC, Avidity Partners Management LP, RA CAPITAL MANAGEMENT, L.P., MARSHALL WACE, LLP, and HHLR ADVISORS, LTD.. This page lists 51 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.